The Gap in Supplemental Nutrition Assistance Program Participation in Pediatric Sickle Cell Disease

Callie Fry, Boston Children's Hospital / Dana Farber Cancer Institute, Boston, MA, United States; Morgan A. Paul, Dana Farber Cancer Institute, Boston, MA, United States; McKenzie Griffin, Dana Farber/Boston Children's Hospital, Boston, MA, United States; Sunyu Kang, Boston Children's Hospital, Somerville, MA, United States; Rahela Aziz-Bose, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, United States; Leanne Duhaney, Boston Children's Hospital, Boston, MA, United States; Puja Umaretiya, University of Texas Southwestern Medical School, Dallas, TX, United States; Natasha Archer, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center; Harvard Medical School, BOston, MA, United States; Kira Bona, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA, United States; Colleen Kelly, Boston Children's Hospital, Boston, MA, United States